Medicamen Biotech Share Price
Start SIP in Medicamen Biotech
Start SIPMedicamen Biotech Performance
Day Range
- Low 556
- High 591
52 Week Range
- Low 355
- High 730
- Open Price579
- Previous Close579
- Volume64362
Medicamen Biotech Investment Rating
-
Master Rating:
-
Medicamen Biotech has an operating revenue of Rs. 180.41 Cr. on a trailing 12-month basis. An annual revenue growth of 27% is outstanding, Pre-tax margin of 7% is okay, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 30% and 19% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 22 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 44 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 41 | 45 | 44 | 43 | 41 | 37 |
| Operating Expenses Qtr Cr | 37 | 38 | 39 | 37 | 33 | 30 |
| Operating Profit Qtr Cr | 5 | 7 | 6 | 6 | 7 | 7 |
| Depreciation Qtr Cr | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest Qtr Cr | 1 | 2 | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Profit Qtr Cr | 2 | 3 | 3 | 3 | 4 | 4 |
Medicamen Biotech Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹506.14
- 50 Day
- ₹471.41
- 100 Day
- ₹469.29
- 200 Day
- ₹500.30
- 20 Day
- ₹492.08
- 50 Day
- ₹445.59
- 100 Day
- ₹465.04
- 200 Day
- ₹483.28
Medicamen Biotech Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 590.67 |
| Second Resistance | 608.68 |
| Third Resistance | 626.02 |
| RSI | 71.36 |
| MFI | 89.75 |
| MACD Single Line | 27.43 |
| MACD | 38.65 |
| Support | |
|---|---|
| First Support | 555.32 |
| Second Support | 537.98 |
| Third Supoort | 519.97 |
Medicamen Biotech Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 66,852 | 3,608,002 | 53.97 |
| Week | 117,084 | 5,074,421 | 43.34 |
| 1 Month | 167,351 | 4,844,817 | 28.95 |
| 6 Month | 57,893 | 2,154,789 | 37.22 |
Medicamen Biotech Result Highlights
Medicamen Biotech Synopsis
NSE-Medical-Generic Drugs
Medicamen Biotec is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 172.39 Cr. and Equity Capital is Rs. 12.71 Cr. for the Year ended 31/03/2024. Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594.| Market Cap | 728 |
| Sales | 173 |
| Shares in Float | 0.72 |
| No of funds | 5 |
| Yield | 0.17 |
| Book Value | 3.48 |
| U/D Vol ratio | 3.8 |
| LTDebt / Equity | |
| Alpha | -0.17 |
| Beta | 1.38 |
Medicamen Biotech Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 42.99% | 43.21% | 43.21% | 43.21% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.06% | 0.12% | 0.22% | 0.22% |
| Individual Investors | 31.57% | 31.96% | 31.9% | 31.81% |
| Others | 25.38% | 24.71% | 24.67% | 24.76% |
Medicamen Biotech Management
| Name | Designation |
|---|---|
| Mr. Rahul Bishnoi | Chairman |
| Mr. Ashwani Kumar Sharma | Non Executive Director |
| Dr. Vimal Kumar Shrawat | Non Executive Director |
| Mr. Sanjay Bansal | Non Executive Director |
| Mr. Suresh Kumar Singh | Non Executive Director |
| Mr. Arun Kumar | Independent Director |
| Mr. Harish Pande | Independent Director |
| Ms. Sangeeta Bishnoi | Independent Director |
| Dr. Ravi Kumar Bansal | Independent Director |
| Mrs. Sumita Dwivedi | Independent Director |
Medicamen Biotech Forecast
Price Estimates
Medicamen Biotech Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-13 | Quarterly Results | |
| 2024-05-29 | Audited Results & Final Dividend | |
| 2024-02-12 | Quarterly Results | |
| 2023-11-10 | Quarterly Results | |
| 2023-08-08 | Quarterly Results |
Medicamen Biotech FAQs
What is Share Price of Medicamen Biotech ?
Medicamen Biotech share price is ₹572 As on 07 October, 2024 | 07:35
What is the Market Cap of Medicamen Biotech ?
The Market Cap of Medicamen Biotech is ₹728.1 Cr As on 07 October, 2024 | 07:35
What is the P/E ratio of Medicamen Biotech ?
The P/E ratio of Medicamen Biotech is 104.2 As on 07 October, 2024 | 07:35
What is the PB ratio of Medicamen Biotech ?
The PB ratio of Medicamen Biotech is 3.5 As on 07 October, 2024 | 07:35